Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 54,464 shares at $65.17 ($3.5M) on 2024-04-19, disclosed to the SEC on 2024-04-22.
Scheduled sale ($3.5M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.98 | 10,423 | $677K | 19.1% |
| 2 | $64.98 | 10,423 | $677K | 19.1% |
| 3 | $65.17 | 16,809 | $1.1M | 30.9% |
| 4 | $65.17 | 16,809 | $1.1M | 30.9% |
| Total | $65.10 avg | 54,464 | $3.5M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |